Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


15.10.2018

3 Biol Psychiatry
1 Clin Neuropharmacol
1 J Clin Psychopharmacol
1 Mol Psychiatry
2 Neuropsychopharmacology
1 Neurosci Lett
1 Pharmacopsychiatry
2 PLoS One
7 Psychiatry Res
4 Psychol Med
1 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. PATEL GH
    Cortical Hub Failure in Schizophrenia.
    Biol Psychiatry. 2018;84:e65-e66.
    PubMed     Text format    

  2. BOUDEWYN MA, Carter CS
    Evolving Concepts in Brain Oscillations and Cognitive Control in Schizophrenia.
    Biol Psychiatry. 2018;84:632-633.
    PubMed     Text format    

  3. LIDDLE PF
    Predicting Persisting Disability in Schizophrenia: The Potential of Neuroimaging.
    Biol Psychiatry. 2018;84:629-631.
    PubMed     Text format    


    Clin Neuropharmacol

  4. PATEL N, LeWitt P, Neikrug AB, Kesslak P, et al
    Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson's Disease Psychosis.
    Clin Neuropharmacol. 2018 Oct 9. doi: 10.1097/WNF.0000000000000307.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  5. TANI H, Suzuki T, Wolfgang Fleischhacker W, Tomita M, et al
    Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review.
    J Clin Psychopharmacol. 2018 Oct 8. doi: 10.1097/JCP.0000000000000959.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  6. DOUCET GE, Moser DA, Luber MJ, Leibu E, et al
    Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia.
    Mol Psychiatry. 2018 Oct 3. pii: 10.1038/s41380-018-0269.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  7. GONCALVES VF, Cuperfain AB, Kennedy JL
    Sex differences in schizophrenia: estrogen and mitochondria.
    Neuropsychopharmacology. 2018 Oct 7. pii: 10.1038/s41386-018-0228.
    PubMed     Text format    

  8. LEGIND CS, Broberg BV, Mandl RCW, Brouwer R, et al
    Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a (1)[H]-spectroscopy twin study.
    Neuropsychopharmacology. 2018 Oct 9. pii: 10.1038/s41386-018-0236.
    PubMed     Text format     Abstract available


    Neurosci Lett

  9. HAN M, Deng C
    BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia.
    Neurosci Lett. 2018 Oct 9. pii: S0304-3940(18)30691.
    PubMed     Text format     Abstract available


    Pharmacopsychiatry

  10. KROC A, Debicka M, Wierzbicka A, Wolkow L, et al
    Sertindole: EEG Analysis, Tolerability, and Clinical Efficacy.
    Pharmacopsychiatry. 2018;51:144-147.
    PubMed     Text format     Abstract available


    PLoS One

  11. JOO SW, Yoon W, Shon SH, Kim H, et al
    Altered white matter connectivity in patients with schizophrenia: An investigation using public neuroimaging data from SchizConnect.
    PLoS One. 2018;13:e0205369.
    PubMed     Text format     Abstract available

  12. SHIMADA T, Ohori M, Inagaki Y, Shimooka Y, et al
    Correction: A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.
    PLoS One. 2018;13:e0205549.
    PubMed     Text format     Abstract available


    Psychiatry Res

  13. SMITH LM, Onwumere J, Craig T, Kuipers E, et al
    Caregiver correlates of patient-initiated violence in early psychosis.
    Psychiatry Res. 2018;270:412-417.
    PubMed     Text format     Abstract available

  14. KRANE-GARTISER K, Henriksen TEG, Morken G, Vaaler AE, et al
    Motor activity patterns in acute schizophrenia and other psychotic disorders can be differentiated from bipolar mania and unipolar depression.
    Psychiatry Res. 2018;270:418-425.
    PubMed     Text format     Abstract available

  15. KASANOVA Z, Oorschot M, Myin-Germeys I
    Social anhedonia and asociality in psychosis revisited. An experience sampling study.
    Psychiatry Res. 2018;270:375-381.
    PubMed     Text format     Abstract available

  16. KINCAID D, Shannon C, Boyd A, Hanna D, et al
    An investigation of associations between experience of childhood trauma and political violence and theory of mind impairments in schizophrenia.
    Psychiatry Res. 2018;270:293-297.
    PubMed     Text format     Abstract available

  17. KINSON RM, Hon C, Lee H, Abdin EB, et al
    Stigma and discrimination in individuals with first episode psychosis; one year after first contact with psychiatric services.
    Psychiatry Res. 2018;270:298-305.
    PubMed     Text format     Abstract available

  18. MA JH, Sun XY, Guo TJ, Barot E, et al
    Association on DISC1 SNPs with schizophrenia risk: A meta-analysis.
    Psychiatry Res. 2018;270:306-309.
    PubMed     Text format     Abstract available

  19. SACCHETTI E, Valsecchi P, Tamussi E, Paulli L, et al
    Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.
    Psychiatry Res. 2018;270:357-364.
    PubMed     Text format     Abstract available


    Psychol Med

  20. ANDERSON KK, Norman R, MacDougall AG, Edwards J, et al
    Estimating the incidence of first-episode psychosis using population-based health administrative data to inform early psychosis intervention services.
    Psychol Med. 2018 Oct 12:1-9. doi: 10.1017/S0033291718002933.
    PubMed     Text format     Abstract available

  21. RADHAKRISHNAN R, Guloksuz S, Ten Have M, de Graaf R, et al
    Interaction between environmental and familial affective risk impacts psychosis admixture in states of affective dysregulation.
    Psychol Med. 2018 Oct 4:1-11. doi: 10.1017/S0033291718002635.
    PubMed     Text format     Abstract available

  22. QUATTRONE D, Di Forti M, Gayer-Anderson C, Ferraro L, et al
    Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.
    Psychol Med. 2018 Oct 4:1-14. doi: 10.1017/S0033291718002131.
    PubMed     Text format     Abstract available

  23. MALLARD TT, Harden KP, Fromme K
    Genetic risk for schizophrenia is associated with substance use in emerging adulthood: an event-level polygenic prediction model.
    Psychol Med. 2018 Oct 12:1-9. doi: 10.1017/S0033291718002817.
    PubMed     Text format     Abstract available


    Schizophr Res

  24. MAHMOOD Z, Clark JMR, Twamley EW
    Compensatory Cognitive Training for psychosis: Effects on negative symptom subdomains.
    Schizophr Res. 2018 Oct 4. pii: S0920-9964(18)30602.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: